This site is intended for Healthcare Professionals only.

Search here...

Tag: Biohaven Pharmaceuticals

spot_imgspot_img

Acute migraine? NICE recommends Pfizer’s rimegepant as potential option

News PB Staff Writer PB Staff Writer -
The National Institute for Health and Care Excellence (NICE) has released conclusive draft guidance, suggesting Pfizer's Vydura (rimegepant) as a choice for treating acute...

Pfizer to pay Biohaven $11.6 bln to tap migraine market

News PB Staff Writer PB Staff Writer -
Pfizer said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceuticals, making a big bet on its ability to boost sales of...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Former NPA director Phil Galt named new Cegedim Rx UK managing director

News 0
Phill Galt replaces Adam Dennett who stepped down from...

Collaboration and partnership: The way forward with community pharmacy

Guest Blog 0
Professor Mahendra G Patel elucidates how pharmacy professionals working...

Sigma Conference 2024: Sector says Pharmacy First won’t solve funding crisis

Exclusive 0
Demands for the next contractual framework include additional funding...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.